Search Within

David H Ilson

Formats
  1. Journal Article (209)
  2. Meeting Abstract (168)
  3. Book Section (20)
  4. Review (13)
  5. Editorial (9)
  6. Conference Paper (6)
  7. Guidelines (3)
  8. Correspondence (2)
  9. Book Whole (1)
  10. Miscellaneous (1)
  11. Research Letter (1)
Groups
  1. Department of Medicine (433)
  2. Gastrointestinal Oncology Service (433)
  3. Solid Tumor Oncology Division (433)
  4. Center for Pancreatic Cancer Research (186)
  5. Surgery (136)
  6. Survivorship Research (127)

More Groups

People
  1. David Kelsen (132)
  2. Geoffrey Ku (122)
  3. Yelena Janjigian (111)
  4. Marinela Capanu (65)
  5. Laura Tang (60)
  6. Manjit Bains (51)

More People

Years
  1. 2025 (5)
  2. 2024 (16)
  3. 2023 (24)
  4. 2022 (21)
  5. 2021 (22)
  6. 2020 (20)

More Years

Publications
  1. Journal of Clinical Oncology (135)
  2. Annals of Oncology (28)
  3. International Journal of Radiation Oncology, Biology, Physics (15)
  4. Journal of the National Comprehensive Cancer Network (14)
  5. Annals of Surgical Oncology (13)
  6. Cancer (12)

More Publications

Publishers
  1. American Society of Clinical Oncology (137)
  2. Elsevier Inc. (57)
  3. Oxford University Press (41)
  4. Springer (32)
  5. Lippincott Williams & Wilkins (22)
  6. Wiley Blackwell (18)

More Publishers

Results (433)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Zolbetuximab + CAPOX in 1L claudin-18.2+ (CLDN18.2+)/HER2− locally advanced (LA) or metastatic gastric or gastroesophageal junction (mG/GEJ) adenocarcinoma: Primary phase 3 results from GLOW
    Meeting Abstract

    Xu, R. H.; Shitara, K.; Ajani, J. A.; Bang, Y. J.; Enzinger, P. C.; Ilson, D. H.; Lordick, F.; Van Cutsem, E.; Gallego Plazas, J.; Huang, J.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Clinical importance of clonal hematopoiesis in metastatic gastrointestinal tract cancers
    Journal Article

    Diplas, B. H.; Ptashkin, R.; Chou, J. F.; Sabwa, S.; Foote, M. B.; Rousseau, B.; Argilés, G.; White, J. R.; Stewart, C. M.; Bolton, K.; more...
    JAMA Network Open (2023)

    Fulltext@MSK | Save
  • Induction FOLFOX and PET-directed chemoradiation for locally advanced esophageal adenocarcinoma
    Journal Article

    Carr, R. A.; Hsu, M.; Harrington, C. A.; Tan, K. S.; Bains, M. S.; Bott, M. J.; Ilson, D. H.; Isbell, J. M.; Janjigian, Y. Y.; Maron, S. B.; more...
    Annals of Surgery (2023)

    Fulltext@MSK | Save
  • Zolbetuximab + mFOLFOX6 as first-line (1L) treatment for patients (pts) withclaudin-18.2+ (CLDN18.2+) / HER2− locally advanced (LA) unresectable or metastatic gastric or gastroesophageal junction (mG/GEJ) adenocarcinoma: Primary results from phase 3 SPOTLIGHT study
    Meeting Abstract

    Shitara, K.; Lordick, F.; Bang, Y. J.; Enzinger, P. C.; Ilson, D. H.; Shah, M. A.; Van Cutsem, E.; Xu, R. H.; Aprile, G.; Xu, J.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Differences in genomic profiles of gastric adenocarcinoma in the US and Japan
    Meeting Abstract

    Nakauchi, M.; Court, C.; Walsh, H. S.; Chatila, W. K.; Shimada, S.; Vardhana, S.; Tang, L. H.; Coit, D. G.; Janjigian, Y. Y.; Maron, S. B.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Regorafenib (REGO) with nivolumab (NIVO) and FOLFOX in HER2 negative esophagogastric cancer (EGC)
    Meeting Abstract

    Cytryn, S.; Joshi, S.; Ku, G. Y.; Maron, S. B.; Desai, A.; Yang, J.; Rao, D.; Goldberg, Z.; Sugarman, R.; Antoine, A.; more...
    Annals of Oncology (2022)

    Fulltext@MSK | Save
  • Pooled safety analysis from phase III studies of trifluridine/tipiracil in patients with metastatic gastric or gastroesophageal junction cancer and metastatic colorectal cancer
    Journal Article

    Van Cutsem, E.; Hochster, H.; Shitara, K.; Mayer, R.; Ohtsu, A.; Falcone, A.; Yoshino, T.; Doi, T.; Ilson, D. H.; Arkenau, H. T.; more...
    ESMO Open (2022)

    Fulltext@MSK | Save
  • Durvalumab (D) and PET-directed chemoradiation (CRT) after induction FOLFOX for esophageal adenocarcinoma: Final results
    Meeting Abstract

    Cowzer, D.; Wu, A. J. C.; Sihag, S.; Walch, H. S.; Park, B. J.; Jones, D. R.; Gu, P.; Maron, S. B.; Sugarman, R.; Chalasani, S. B.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Supporting patients with cancer after Dobbs v. Jackson Women's Health Organization
    Editorial

    Shuman, A. G.; Aapro, M. S.; Anderson, B.; Arbour, K.; Barata, P. C.; Bardia, A.; Bruera, E.; Chabner, B. A.; Chen, H.; Choy, E.; more...
    The Oncologist (2022)

    Fulltext@MSK | Save
  • Impact of lung and heart radiation dose during preoperative chemoradiation on overall survival (OS) in esophageal cancer (EC) – Secondary analysis of CALGB 80803 (Alliance)
    Meeting Abstract

    Lehrer, E. J.; Geyer, S.; Goodrich, A.; Ilson, D. H.; Noonan, A.; Dumane, V. A.; Goodman, K. A.
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save